Skip to main content

Advertisement

Table 2 Unadjusted and age-adjusted factors for reported consistent gel use

From: Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda

Characteristic N(%) Consistent gel usersn(%) uOR (95% CI) LRTPvalue Age aOR (95% CI) LRTPvalue
All participants 544 (100) 369 (67.8)     
Age group       
17– 24 92 (16.9) 44 (47.8) 1 <0.01 N/A  
25–34 237 (43.6) 172 (72.6) 2.9 (1.8–4.8)    
≥35 215 (39.5) 153 (71.2) 2.7 (1.6–4.5)    
Religion       
Christian 472 (86.8) 319 (67.6) 1 0.75 1 0.54
Muslim 72 (13.2) 50 (69.4) 1.1 (0.6–1.9)   1.2 (0.7–2.1)  
Level of education       
None 81 (14.9) 54 (66.7) 1 0.81 1 0.52
Some education 463 (85.1) 315 (68.0) 1.1 (0.6–1.8)   1.2 (0.7–2.0)  
Employment status       
Employed 92 (16.9) 55 (59.8) 1 0.07 1 0.11
Unemployed 452 (83.1) 314 (69.5) 1.5 (1.0–2.4)   1.5 (0.9–2.4)  
Family planning use       
No 227 (41.7) 155 (68.3) 1 0.85 1 0.86
Yes 317 (58.3) 214 (67.5) 0.9 (0.7–1.4)   1.0 (0.7–1.4)  
Condom use       
No 190 (34.9) 123 (64.7) 1 0.26 1 0.41
Yes 354 (65.1) 246 (69.5) 1.2 (0.9–1.8)   1.2 (0.8–1.7)  
Perceived sexual experience using gel       
Gel made sex less enjoyable 41 (7.5) 26 (63.4) 1 0.48 1 0.27
Gel left sexual pleasure the same 317 (58.3) 209 (65.9) 1.1 (0.6–2.2)   1.2 (0.6–2.4)  
Gel made sex more enjoyable 186 (34.2) 134 (72.0) 1.5 (0.7–3.2)   1.6 (0.8–3.4)  
Pregnancy status       
Positive 90 (16.5) 57 (63.3) 1 0.32 1 0.11
Negative 454 (83.5) 312 (68.7) 1.3 (0.8–2.0)   1.5 (0.9–2.5)  
Rooms used for sleeping in at home       
One 187 (34.4) 111 (59.4) 1 0.02 1 0.03
Two 177 (32.5) 120 (67.8) 1.4 (0.9–2.2)   1.2 (0.8–1.9)  
Three+ 180 (33.1) 138 (76.7) 2.2 (1.4–3.5)   1.9 (1.2–3.1)  
Trial arm       
Placebo 275 (50.6) 183 (66.6) 1 0.52 1 0.58
PRO2000 (0.5%) 269 (49.4) 186 (69.1) 1.1 (0.8–1.6)   1.1 (0.8–1.6)  
  1. uOR, unadjusted odds ratio; CI, confidence interval; LRT, likelihood ratio test; Age aOR, age-adjusted odds ratio.